全文获取类型
收费全文 | 2311篇 |
免费 | 203篇 |
出版年
2022年 | 21篇 |
2021年 | 36篇 |
2020年 | 28篇 |
2019年 | 28篇 |
2018年 | 38篇 |
2017年 | 25篇 |
2016年 | 34篇 |
2015年 | 76篇 |
2014年 | 105篇 |
2013年 | 129篇 |
2012年 | 154篇 |
2011年 | 157篇 |
2010年 | 96篇 |
2009年 | 67篇 |
2008年 | 127篇 |
2007年 | 128篇 |
2006年 | 132篇 |
2005年 | 122篇 |
2004年 | 111篇 |
2003年 | 128篇 |
2002年 | 113篇 |
2001年 | 29篇 |
2000年 | 20篇 |
1999年 | 30篇 |
1998年 | 30篇 |
1997年 | 15篇 |
1996年 | 20篇 |
1995年 | 23篇 |
1994年 | 24篇 |
1993年 | 19篇 |
1992年 | 18篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 12篇 |
1988年 | 12篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1980年 | 18篇 |
1978年 | 11篇 |
1977年 | 15篇 |
1976年 | 20篇 |
1975年 | 16篇 |
1974年 | 8篇 |
1973年 | 12篇 |
1971年 | 10篇 |
排序方式: 共有2514条查询结果,搜索用时 15 毫秒
991.
992.
Overexpression of CYB5R3 and NQO1, two NAD+‐producing enzymes,mimics aspects of caloric restriction
下载免费PDF全文
![点击此处可从《Aging cell》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Alberto Diaz‐Ruiz Michael Lanasa Joseph Garcia Hector Mora Frances Fan Alejandro Martin‐Montalvo Andrea Di Francesco Miguel Calvo‐Rubio Andrea Salvador‐Pascual Miguel A. Aon Kenneth W. Fishbein Kevin J. Pearson Jose Manuel Villalba Placido Navas Michel Bernier Rafael de Cabo 《Aging cell》2018,17(4)
Calorie restriction (CR) is one of the most robust means to improve health and survival in model organisms. CR imposes a metabolic program that leads to increased stress resistance and delayed onset of chronic diseases, including cancer. In rodents, CR induces the upregulation of two NADH‐dehydrogenases, namely NAD(P)H:quinone oxidoreductase 1 (Nqo1) and cytochrome b5 reductase 3 (Cyb5r3), which provide electrons for energy metabolism. It has been proposed that this upregulation may be responsible for some of the beneficial effects of CR, and defects in their activity are linked to aging and several age‐associated diseases. However, it is unclear whether changes in metabolic homeostasis solely through upregulation of these NADH‐dehydrogenases have a positive impact on health and survival. We generated a mouse that overexpresses both metabolic enzymes leading to phenotypes that resemble aspects of CR including a modest increase in lifespan, greater physical performance, a decrease in chronic inflammation, and, importantly, protection against carcinogenesis, one of the main hallmarks of CR. Furthermore, these animals showed an enhancement of metabolic flexibility and a significant upregulation of the NAD+/sirtuin pathway. The results highlight the importance of these NAD+ producers for the promotion of health and extended lifespan. 相似文献
993.
Complex-formation between reduced xanthine oxidase and purine substrates demonstrated by electron paramagnetic resonance 总被引:11,自引:11,他引:0
The origin of the Rapid molybdenum electron-paramagnetic-resonance signals, which are obtained on reducing xanthine oxidase with purine or with xanthine, and whose parameters were measured by Bray & Vänngård (1969), was studied. It is concluded that these signals represent complexes of reduced enzyme with substrate molecules. Xanthine forms one complex at high concentrations and a different one at low concentrations. Purine forms a complex indistinguishable from the low-concentration xanthine complex. There are indications that some other substrates also form complexes, but uric acid, a reaction product, does not appear to do so. The possible significance of the complexes in the catalytic cycle of the enzyme is discussed and it is suggested that they represent substrate molecules bound at the reduced active site, waiting their turn to react there, when the enzyme has been reoxidized. Support for this role for the complexes was deduced from experiments in which frozen samples of enzyme–xanthine mixtures, prepared by the rapid-freezing method, were warmed until the signals began to change. Under these conditions an increase in amplitude of the Very Rapid signal took place. Data bearing on the origin of the Slow molybdenum signal are also discussed. This signal disappears only slowly in the presence of oxygen, and its appearance rate is unaffected by change in the concentration of dithionite. It is concluded that, like other signals from the enzyme, it is due to Mov but that a slow change of ligand takes place before it is seen. The Slow species, like the Rapid, seems capable of forming complexes with purines. 相似文献
994.
995.
996.
997.
998.
999.
1000.
High performance tangential flow filtration 总被引:2,自引:0,他引:2
van Reis R Gadam S Frautschy LN Orlando S Goodrich EM Saksena S Kuriyel R Simpson CM Pearl S Zydney AL 《Biotechnology and bioengineering》1997,56(1):71-82
Conventional tangential flow filtration (TFF) has traditionally been limited to separation of solutes that differ by about ten-fold in size. Wide pore-size distributions, membrane fouling, and concentration polarization phenomena have commonly been cited as reasons for this limitation. The use of TFF in the biotechnology industry has therefore been restricted to cell-protein, virus-protein, and protein-buffer separations. A multi-disciplinary team with industrial and academic members was formed to overcome these limitations and enable protein-protein separations using High Performance TFF (HPTFF) systems. Pore-size distributions have been improved with the development of new membrane formulation and casting techniques. Membrane fouling has been controlled by operating in the transmembrane pressure-dependent regime of the filtrate flux curve and by carefully controlling fluid dynamic start-up conditions. Concentration polarization was exploited to enhance, rather than limit, the resolution of solutes. Concentration polarization has also been controlled by operating a co-current filtrate stream that maintains transmembrane pressure constant along the length of the TFF module. High yields and purification factors were obtained even with small differences in protein sieving. IgG-BSA and BSA monomer-oligomer mixtures have successfully been separated with these systems. HPTFF technology provides a competitive purification tool to complement chromatographic processing of proteins. (c) 1997 John Wiley & Sons, Inc. Biotechnol Bioeng 56: 71-82, 1997. 相似文献